OECD TG 408

OECD TG 408, OECD Test Guidelines for the Testing of Chemicals, Section 4 (Health Effects) as part of the ‘90-day oral toxicity study in rodents following repeated administration’, i.e. the 90-day oral toxicity study following repeated administration to rodents. It was first adopted in 1981 and updated in 1998. The test is an in vivo toxicity study designed to evaluate the toxic effects, target organs and dose-response relationship of a substance following repeated oral administration over a period of 90 days.

The basic principle of the test is as follows:

  • The test substance is usually administered to rats daily for 90 days, either by gavage or, if necessary, via their feed or drinking water.
  • As a rule, three dose groups and a control group are used; the dose levels are determined on the basis of a 28-day preliminary study (TG 407) or existing data. The high dose should produce toxic effects but should not result in a high mortality rate or excessive pain.
  • As a rule, at least 20 animals (10 males + 10 females) are used in each group; additional animals may be included for blood and tissue analyses.
  • The animals are clinically monitored on a daily basis; their body weight and feed and water intake are recorded regularly.
  • At the end of the study, haematology, clinical chemistry and urinalysis tests are carried out.
  • The weights of the organs are measured and a macroscopic post-mortem examination is carried out.
  • A histopathological examination of the major organs and tissue samples is carried out.
  • Where necessary, endocrine-sensitive endpoints (thyroid hormones, sperm parameters, oestrous cycle) and neurotoxicity indicators may be assessed.

The key parameters reported in the study are as follows:

  • Dosages used (mg/kg/day) and route of administration
  • Clinical observations and their onset
  • Changes in body weight and feed/water intake
  • Haematological parameters (complete blood count, white blood cell differential, etc.)
  • Clinical chemistry parameters (liver and kidney function tests, electrolytes, glucose, lipids, etc.)
  • Results of the urine analysis
  • Organ weights (absolute and relative)
  • Findings from the macroscopic post-mortem examination
  • Histopathological findings (target organs and all major tissues)
  • NOAEL/LOAEL values and dose-response relationship
  • Data on measurement uncertainty and repeatability

What is the purpose of the study?

OECD TG 408 is being carried out for the following scientific and regulatory purposes:

  • Assessment of toxicity following repeated administration: identification of systemic toxic effects and target organs following 90 days of repeated oral exposure
  • Assessment of the dose-response relationship: determination of the NOAEL and LOAEL values
  • Assessment of target organ toxicity: evaluation of histopathological changes, particularly in the liver, kidneys, haematopoietic system, endocrine organs and reproductive organs
  • Provision of preliminary data for chronic studies: As a basis for dose setting in studies on chronic toxicity (TG 452) and carcinogenicity (TG 451, TG 453)
  • Support with the preparation of authorisation dossiers: for use in safety assessments under REACH, for biocides, plant protection products, medicinal products, pesticides and industrial chemicals
  • Contribution to risk assessment: Provision of baseline data for risk assessment in scenarios involving repeated exposure
  • Preliminary assessment of endocrine effects: Where appropriate, screening for endocrine activity using endpoints such as thyroid hormones, sperm parameters and the oestrous cycle
  • Evidence-based approach: A contribution to the holistic assessment of the substance in conjunction with other toxicological, physicochemical and exposure data

OECD TG 408 does not provide any direct information on acute toxicity or carcinogenicity; these effects must be assessed in separate tests. The results should be interpreted in the context of the chemical structure of the substance, the data from the 28-day study (TG 407), chronic/carcinogenicity studies and the exposure assessment.

As part of our nano-testing services, we conduct 90-day repeated-dose oral toxicity studies in accordance with OECD TG 408 with scientific rigour, utilising our accredited laboratory facilities and quality management system. Our scope of services includes the following:

  • Preparation of a study protocol in accordance with OECD TG 408
  • Scientific justification for the dose levels based on the physicochemical properties of the test substance, the TG 407 data and the available toxicity information
  • Selection of a suitable carrier (vehicle) and assessment of solubility and stability
  • Determination of species, sex, age, route of administration and observation period
  • Planning of the control and treatment groups, the number of animals and additional analysis groups
  • Compliance with ethical approval and animal welfare requirements

Please feel free to contact Nano-Test for information on study design, dose determination, histopathological planning, sample collection conditions, the testing schedule and reporting procedures for your 90-day repeated-dose oral toxicity studies in accordance with OECD TG 408.